A case report reveals significant improvement in ITP after eradicating helicobacter pylori in a young patient, suggesting its role in pediatric ITP.
Helicobacter pylori (H. pylori) infection is increasingly recognized as a trigger for secondary immune thrombocytopenia (ITP). We report the case of a 4-year-old boy with acute ITP refractory to first-line immunosuppressive therapy who showed significant clinical improvement following the detection and eradication of an H. pylori infection. This case underscores the importance of considering H. pylori as an underlying etiology in pediatric patients presenting with ITP, particularly those with gastrointestinal symptoms or a suboptimal response to standard treatment.
No takes yet. Share an insight, caveat, or question.
Almadani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: